Creative Biolabs-Immuno-oncology

Anti-GPC2 (clone LH3) SynExpress pL-R-P-X Modified CD8+ T cells (CAT#: ITS-1224-CR525)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target GPC2 (clone LH3). We employs the Retrovirus (pL-RFP-PAX-XbaI) vector components and the SynExpress system of the Histone modification sites RNA Editing/Delayed feedback for a robust and sustained response against cancers.
Host
humanized
Target
GPC2
Clone
LH3
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
pL
Effector Gene
PAX
Insertion Sites
XbaI
Gene Modification
RNA Editing
Modification Domain
Histone modification sites
Carrier Type
Retrovirus
Transformation Accuracy
0.89
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving